INBX vs SCHD
Inhibrx Biosciences, Inc. (INBX) versus SCHD (SCHD) — a side-by-side from cached financials, not a winner call.
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
SCHD (SCHD) common stock.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
SCHD does not have a complete income-statement cache yet.
INBX currently screens at market cap $1.28B. SCHD currently screens at market cap $0.
Not investment advice. Open the INBX and SCHD stock pages for the full models.
Not investment advice.